Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211783 · ClinicalTrials.gov registry record
Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 71
- Enrollment target
NCT00211783 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 71 participants.
The verdict
NCT00211783 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
This study investigates face processing, response inhibition and phoneme processing in autistic adults by fMRI.
Interventions
- PROCEDURE fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2004-11 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211783
The ClinicalTrials.gov registry entry for NCT00211783 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT00211783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211783 about?
NCT00211783 is a clinical study titled "Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism". This study investigates face processing, response inhibition and phoneme processing in autistic adults by fMRI.
What is the current status of trial NCT00211783?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2004-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00211783?
The interventions under investigation include: fMRI (PROCEDURE).
Who is sponsoring clinical trial NCT00211783?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.